Cargando…
Pneumococcal Polysaccharide Vaccine Ameliorates Murine Lupus
Current guidelines encourage administering pneumococcal vaccine Prevnar-13 to patients with lupus, but whether such vaccinations affect disease severity is unclear. To address this issue, we treated 3-month-old MRL-lpr mice, that spontaneously develop a lupus-like syndrome, with Prevnar-13 or vehicl...
Autores principales: | Cantarelli, Chiara, Guglielmo, Chiara, Hartzell, Susan, Salem, Fadi El, Andrighetto, Sofia, Gazivoda, Victor P., Fiaccadori, Enrico, La Manna, Gaetano, Zaza, Gianluigi, Leventhal, Jeremy, Tassiulas, Ioannis, Cravedi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879550/ https://www.ncbi.nlm.nih.gov/pubmed/31824490 http://dx.doi.org/10.3389/fimmu.2019.02695 |
Ejemplares similares
-
Decay-Accelerating Factor Restrains Complement Activation and Delays Progression of Murine cBSA-Induced Membranous Nephropathy
por: Budge, Kelly L, et al.
Publicado: (2023) -
Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
por: Cantarelli, Chiara, et al.
Publicado: (2021) -
Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019) -
Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis
por: Angeletti, Andrea, et al.
Publicado: (2020) -
Erythropoietin in Lupus: Unanticipated Immune Modulating Effects of a Kidney Hormone
por: Eswarappa, Meghana, et al.
Publicado: (2021)